News
FDA and the Avicenna Alliance sign an extension of their Memorandum of Understanding (MoU)
On October 13 Namandjé N. Bumpus, Chief Scientist FDA and Thierry Marchal , Secretary General of the Avicenna Alliance have signed an extension of their Memorandum of Understanding.
Prof David Fletcher is the new APAC TF Co-Chair
We are delighted to welcome Prof David Fletcher as the new APAC TF Co-Chair.
Avicenna Notified Bodies & EMA TFs’ Survey
Are you actively involved in the realm of computational modeling and simulation? The Avicenna Alliance is seeking your valuable insights in this survey (open until December 31, 2023):
AVICENNA DAYS (AAD) 2023 HAVE BEEN A GREAT SUCCESS !!!
The AAD 2023 have been an amazing success bringing together the in silico community!
Avicenna Alliance Advocates for Harmonized In Silico Regulation in Brazil
On October 4th, the Avicenna Alliance launched a mission to Brazil, aiming to advocate for the harmonization of legislation on digital evidence and in silico simulations in medical product regulation. The delegation engaged with key stakeholders in Brasília, including the Brazilian Parliament and ANVISA, highlighting the transformative role of in silico technologies in enhancing regulatory efficiency, reducing development costs and timelines, and improving patient safety.
Welcome Aimed Trial!
We are very proud to welcome Aimed Trial among the Avicenna Alliance members.
